We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

186 hedge funds and large institutions have $1.26B invested in Cardiovascular Systems, Inc. in 2019 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 60 increasing their positions, 50 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 16

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

50% more capital invested

Capital invested by funds: $839M → $1.26B (+$420M)

26% more funds holding

Funds holding: 148186 (+38)

20% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 50

46% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.5M

Holders
186
Holders Change
+38
Holders Change %
+25.68%
% of All Funds
4.03%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
54
Increased
60
Reduced
50
Closed
16
Calls
$1.89M
Puts
$3.5M
Net Calls
-$1.61M
Net Calls Change
-$1.62M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$10.2M +$6.26M +184,691 +235%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$8.64M +$2.06M +60,810 +37%
GF
28
Gabelli Funds
New York
$8.38M -$724K -21,366 -9%
Citadel Advisors
29
Citadel Advisors
Florida
$8.34M -$546K -16,112 -7%
Prudential Financial
30
Prudential Financial
New Jersey
$8.27M +$6.15M +181,390 +558%
Charles Schwab
31
Charles Schwab
California
$7.71M +$275K +8,123 +4%
GKIM
32
GW&K Investment Management
Massachusetts
$7.57M -$1.05M -31,114 -14%
FLAM
33
First Light Asset Management
Minnesota
$7.27M -$9.96M -293,993 -61%
Man Group
34
Man Group
United Kingdom
$7.25M +$149K +4,384 +2%
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$6.66M +$3.6M +106,238 +161%
Morgan Stanley
36
Morgan Stanley
New York
$6.4M +$2.55M +75,302 +83%
TCIM
37
TIAA CREF Investment Management
New York
$6.1M -$1.22M -36,081 -19%
TAM
38
THB Asset Management
Connecticut
$6.1M -$724K -21,362 -12%
PPA
39
Parametric Portfolio Associates
Washington
$5.6M +$4.23M +124,664 +620%
FPC
40
Falcon Point Capital
California
$5.56M +$4.23M +124,676 +651%
GI
41
GAMCO Investors
Connecticut
$5.35M +$1.84M +54,319 +65%
USAA
42
United Services Automobile Association
Texas
$4.67M +$525K +15,500 +15%
Wells Fargo
43
Wells Fargo
California
$4.41M +$1.92M +56,524 +98%
TA
44
Teton Advisors
New York
$4.29M
Two Sigma Advisers
45
Two Sigma Advisers
New York
$4.13M -$990K -29,200 -21%
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$4.04M +$545K +16,085 +18%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$3.91M +$1.93M +57,041 +129%
AAMU
48
Amundi Asset Management US
Massachusetts
$3.87M +$3.39M +100,000 New
MPI
49
Mairs & Power Inc
Minnesota
$3.69M +$417K +12,292 +15%
QI
50
QS Investors
New York
$3.4M

CSII Hedge Fund Activity: Q1 2019 in Review

186 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2019, worth a combined $1.26B — up 50% from $839M a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new CSII positions and 16 closed out — a net gain of 38 holders — while 60 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $86.3M. The largest seller was PFM Health Sciences, cutting an estimated $39.1M.

  • 186 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2019, up from 148 in Q4 2018.
  • Funds reported $1.26B of Cardiovascular Systems, Inc. stock for Q1 2019, up 50% quarter-over-quarter.
  • 54 funds opened new Cardiovascular Systems, Inc. positions in Q1 2019 and 16 closed out, a net change of +38 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2019 was BlackRock, an estimated $86.3M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2019 was PFM Health Sciences, an estimated $39.1M sold.

Based on aggregated 13F filings for Q1 2019.